Compare Davita Inc (DVA) vs Direxion Daily Semiconductor Bear 3X Shares (SOXS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Davita Inc trades at $230.55 (market cap $14.92B), while Direxion Daily Semiconductor Bear 3X Shares trades at $42.25. Which is the better fit depends on your goals.
| DVA | SOXS | |
|---|---|---|
Market Cap | $14.92B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $235.71 | $1.61K |
52-Week Low | $103.87 | $32.50 |
Enterprise Value | $27.47B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $46.65, up 14.34% on the day amid semiconductor sector volatility. Technical indicators show a neutral overall signal with bearish moving averages. The ETF is scheduled for a 1:10 stock split on July 15, 2026, and declared a $0.04 dividend for H1-2026. Recent news highlights the ETF's role in betting against the AI-driven semiconductor rally, with SOXS down significantly over six months as chip stocks surge.
The outlook for SOXS remains highly speculative, offering leveraged inverse exposure to semiconductors. Key opportunities include hedging against a potential semiconductor downturn, but risks are extreme due to the ETF's bearish structure in a strong bull market. Volatility decay and the sector's momentum pose substantial threats to long-term holders, making it suitable only for tactical, short-term trading.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Direxion Daily Semiconductor Bear 3X Shares
SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →
